Rosendal Susanne, Kristensen Ellids, Giraldi Annamaria G E
Rigshospitalet, Psykiatrisk Klinik, afsnit 7421, København Ø.
Ugeskr Laeger. 2007 Nov 12;169(46):3941-6.
Patients treated for testicular cancer have a higher risk of ejaculatory, orgasmic and erectile dysfunctions compared with healthy males. The causality is not clear. In this paper we assess sexual dysfunction in the different treatment modalities based on primarily 1 meta-analysis and 11 original articles. During treatment, approximately 1/3 of patients experience one or more sexual dysfunctions. Only retroperitodineal surgery is significantly correlated with a specific sexual dysfunction, which is loss of ejaculation. Psychosexual causes seem to be important in the understanding of sexual dysfunctions in the aftermath of testicular-cancer treatment.
与健康男性相比,接受睾丸癌治疗的患者出现射精、性高潮和勃起功能障碍的风险更高。因果关系尚不清楚。在本文中,我们主要基于1项荟萃分析和11篇原创文章评估了不同治疗方式中的性功能障碍。在治疗期间,约三分之一的患者会出现一种或多种性功能障碍。只有腹膜后手术与一种特定的性功能障碍(即射精丧失)显著相关。心理性原因在理解睾丸癌治疗后出现的性功能障碍方面似乎很重要。